For example, PIK3CA was an inclusion criterion in one clinical trial (NCT02957266) for directing cervical carcinoma therapy (45), as well as, ERBB3 and FBXW7 were considered as biomarkers in several clinical trials for malignant solid tumor (Table 3). Here, PIK3CA is linked to cervical carcinoma.